Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1175 clinical trials
Featured trial
Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease

quality of life in patients with moderate to severe Alzheimer's Disease. Treatment will occur at home-based treatment sessions with the device.A potential participant will undergo

mental state examination
stroke
mini-mental state examination
  • 69 views
  • 30 Jul, 2021
  • 9 locations
Featured trial
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, 52-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF SIMUFILAM 100 MG TABLETS IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE

Simufilam is an experimental treatment, meaning that it has not yet been approved by the United States (US) Food and Drug Administration (FDA). In this study, the study medicine will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not …

  • 2 views
  • 25 Mar, 2022
  • 1 location
Featured trial
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease

This study will be conducted to evaluate the efficacy of BAN2401 in participants with early Alzheimer's disease (EAD) by determining the superiority of BAN2401 compared with

acetylcholinesterase inhibitor
acetylcholinesterase
amyloid
memantine
mini-mental state examination
  • 335 views
  • 08 Dec, 2020
  • 1 location
Featured trial
A multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) on slowing progression of mild cognitive impairment due to Alzheimer's disease

A study for patients with mild cognitive impairment due to Alzheimer's disease with short memory loss.  

ginkgo biloba
cholinesterase inhibitors
cognitive decline
cholinesterase
vitamin e
  • 166 views
  • 08 Dec, 2020
  • 1 location
Featured trial
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 52)

The purpose of this study is to determine whether etrasimod is a safe and effective treatment for moderately to severely active ulcerative colitis.  

  • 98 views
  • 08 Dec, 2020
  • 1 location
Featured trial
NICE-AD (Neurostimulation for Cognitive Enhancement in Alzheimer’s Disease)

The NICE-AD study is a home-based clinical trial examining a treatment for Alzheimer’s Disease. We are interested in examining the effects of the device on cognition, mood, and neuroplasticity in patients with Alzheimer’s Disease. 

dementia
  • 32 views
  • 02 Nov, 2021
  • 1 location
Featured trial
The Health and Aging Brain Study: Health Disparities

Alzheimer’s disease is the most common cause of memory problems as we age. However, many things can impact our thinking over time. At HSC, we are working to find new and better ways to treat and prevent memory loss during the aging process. The research we do today aims to …

alzheimer's disease
Accepts healthy volunteers
  • 19 views
  • 14 Jun, 2022
  • 1 location
Featured trial
A PATIENT- AND INVESTIGATOR-BLIND, PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPENLABEL EXTENSION PERIOD

Bepranemab (UCB0107) is being developed with the aim of blocking or reducing the cell-to-cell spread of tau pathology in patients with tau-mediated diseases, such as AD. To date, single ascending doses of bepranemab (up to 120mg/kg) have been evaluated in healthy study participants in two Phase 1 studies and no …

  • 14 views
  • 24 Jun, 2022
  • 1 location
Featured trial
A PHASE III, MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GANTENERUMAB IN PARTICIPANTS AT RISK FOR OR AT THE EARLIEST STAGES OF ALZHEIMER’S DISEASE

This study is designed to evaluate the efficacy and safety of Gantenerumab in participants at risk for or at the earliest stages of Alzheimer’s Disease (AD) 

Accepts healthy volunteers
  • 4 views
  • 24 Jun, 2022
  • 1 location
Featured trial
Mild Dementia/Alzheimer's Disease

Mild Dementia/Alzheimer's Disease

  • 474 views
  • 25 Mar, 2021
  • 1 location